Sepure Instruments Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sepure Instruments Inc. - overview
Established
2011
Location
Suzhou, Jiangsu, China
Primary Industry
Medical Devices & Equipment
About
Based in Suzhou, China and founded in 2011, Sepure Instruments Inc. operates as a biochemical drug isolation and purification testing instrument developer, providing instruments and equipment for the separation and purification of large molecules such as proteins, antibodies, vaccines, peptides, viruses, etc. The company has obtained 10 invention patents and 10 instrument control software systems. The products of the company can be categorized into six categories which are laboratory-grade chromatography system, production-grade chromatography system, chromatography column and packing, instrument accessories, SCG chromatography workstation, high performance liquid chromatograph.
Products within include Third Generation Chromatography System SCG-P, Protein purification system SCG-300 series, Protein Purification System SCG-100 Series, ECS10 Quadruple Preparation System and etc. The company also has cooperation with Sichuan University, Shanghai United Cell Biotechnology Co. , Ltd. and etc.
Current Investors
Nano-Micro, Wujiang Chuangxun Venture Investment, Xuande Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Biotechnology, Medical Equipment Distributors
Website
www.sepuretech.com
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Sepure Instruments Inc. - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.